ENT Liu Knowledge Base Head & neck tumours · physician reviewed
Head and Neck Cancer of Unknown Primary · Prevention & risk

What are the risk factors for head and neck cancer of unknown primary?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: Head and Neck Cancer of Unknown Primary Answer length: short, citable
Quick answer

The main recognised risk factors for head and neck cancer of unknown primary are persistent high-risk HPV-16 infection (HPV-related occult oropharyngeal primary), tobacco and heavy alcohol use (HPV-negative mucosal primary) and EBV infection in endemic regions (occult nasopharyngeal primary). Risks differ by region: North America has a distinctive exposure pattern, so a patient's country of residence is part of the risk assessment. Having a risk factor does not mean a person will develop cancer.

In detail

Risk factors are probabilistic. Many patients have no obvious exposure, and most people with an exposure never develop a head and neck tumour. Tell your clinician about all tobacco, areca nut, alcohol, occupational and viral exposures, because this information changes follow-up planning.

  • Persistent high-risk HPV-16 infection (HPV-related occult oropharyngeal primary)
  • Tobacco and heavy alcohol use (HPV-negative mucosal primary)
  • EBV infection in endemic regions (occult nasopharyngeal primary)
  • Cumulative UV exposure and prior skin cancer (occult cutaneous primary)
  • Male sex and age 40–65 for HPV-related disease
  • Prior incomplete excision of a neck mass before proper work-up

What this means in practice: this answer is part of the “Prevention & risk” section of the Head and Neck Cancer of Unknown Primary topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about head and neck cancer of unknown primary

See all 13 questions in this topic →

Sources for this answer

  1. HPV & Oropharyngeal Cancer US National Institute of Dental and Craniofacial Research · 2025 · About 70% of oropharyngeal cancers in the United States are HPV-positive.
  2. HPV Detection in Oropharyngeal Cancer: A Narrative Review PubMed Central / peer-reviewed review · 2025 · HPV-attributable fraction: ~71% US, ~52% UK, >60% Scandinavia, <20% Southern Europe, ~44% globally.
  3. NCCN Guidelines for Patients: Head and Neck Cancers National Comprehensive Cancer Network · 2025
  4. Head and Neck Cancers (patient information) US National Cancer Institute · 2025

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

← Previous questionWhere in the world is head and neck cancer of unknown primary most common? Next question →What are the early signs of head and neck cancer of unknown primary?

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.